Tursi Antonio, Brandimarte Giovanni, Giorgetti Gian Marco, Elisei Walter
Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria (BA), Italy.
Dig Dis Sci. 2006 Mar;51(3):461-5. doi: 10.1007/s10620-006-3155-6.
Lactose malabsorption (LM) may be secondary to several small bowel diseases, and small intestinal overgrowth (SIBO) may be one of them. We looked for a correlation between symptomatic diverticular disease of the colon and LM and assessed whether this correlation may be related to SIBO. Ninety consecutive patients (pts; 39 males, 51 females; mean age, 67.2 years; range, 32-91 years) affected by symptomatic uncomplicated diverticular disease of the colon were evaluated to assess orocecal transit time (OCTT), SIBO, and LM by lactulose and lactose H2 breath test (H2-BT) at entry and after 8 weeks of treatment. OCTT was delayed in 67 of 90 pts (74.44%). Fifty-three of 90 pts (58.88%) showed SIBO, and OCTT was normal in 23 of 90 pts (25.56%). LM was diagnosed in 59 of 90 pts (65.55%): 49 of 59 (71.74%) were simultaneously affected by SIBO and delayed OCTT (and thus 49 of 53 pts [92.45%] with delayed OCTT and SIBO were affected by LM); 3 of 59 pts (5.09%) showed only delayed OCTT; 7 of 59 pts (11.86%) did not show either SIBO or delayed OCTT. The association of LM and SIBO was statistically significant (P < 0.001). Seventy-nine of 86 pts (91.86%) showed normal OCTT, while OCTT remained prolonged but shorter in the remaining 7 pts (8.14%). SIBO was eradicated in all pts completing the study, while a new lactulose H2-BT showed persistence of SIBO in one pt with recurrence of symptomatic diverticular disease. Forty-seven of 59 pts (79.66%) had a normal lactose H2-BT (P < 0.002), while 12 of 59 pts (20.34%) showed persistence of LM. LM disappeared in 46 of 49 pts (93.88%) concurrently with normalization of OCTT and eradication of SIBO (P < 0.002); it also disappeared in 1 of 3 pts (33.33%) previously affected by delayed OCTT (without SIBO) and LM concurrently with normalization of OCTT. On the contrary, it persisted in all pts with normal OCTT and absence of SIBO. Moreover, it persisted also in the pt with recurrence of symptomatic diverticular disease and persistence of SIBO. In conclusion, most pts affected by symptomatic uncomplicated diverticular disease of the colon showed LM, and in more than 70% of cases it disappeared after successful treatment of the colonic disease.
乳糖吸收不良(LM)可能继发于多种小肠疾病,小肠细菌过度生长(SIBO)可能是其中之一。我们探寻了有症状的结肠憩室病与LM之间的相关性,并评估这种相关性是否可能与SIBO有关。对90例连续的有症状的非复杂性结肠憩室病患者(39例男性,51例女性;平均年龄67.2岁;范围32 - 91岁)进行评估,在入组时以及治疗8周后,通过乳果糖和乳糖氢气呼气试验(H2 - BT)评估口盲肠转运时间(OCTT)、SIBO和LM。90例患者中有67例(74.44%)OCTT延迟。90例患者中有53例(58.88%)显示存在SIBO,90例患者中有23例(25.56%)OCTT正常。90例患者中有59例(65.55%)被诊断为LM:59例中的49例(71.74%)同时存在SIBO和OCTT延迟(因此53例OCTT延迟且有SIBO的患者中有49例[92.45%]存在LM);59例中的3例(5.09%)仅显示OCTT延迟;59例中的7例(11.86%)既没有SIBO也没有OCTT延迟。LM与SIBO的关联具有统计学意义(P < 0.001)。86例患者中有79例(91.86%)OCTT正常,而其余7例(8.14%)OCTT仍延长但有所缩短。所有完成研究的患者中SIBO均被根除,而一项新的乳果糖H2 - BT显示,1例有症状的结肠憩室病复发患者仍存在SIBO。59例患者中有47例(79.66%)乳糖H2 - BT正常(P < 0.002),而59例患者中有12例(20.34%)仍存在LM。49例患者中有46例(93.88%)的LM随着OCTT正常化和SIBO根除而消失(P < 0.002);3例先前OCTT延迟(无SIBO)且有LM的患者中有1例(33.33%)的LM随着OCTT正常化而消失。相反,所有OCTT正常且无SIBO的患者中LM持续存在。此外,有症状的结肠憩室病复发且存在SIBO的患者中LM也持续存在。总之,大多数有症状的非复杂性结肠憩室病患者存在LM,并且在超过70%的病例中,结肠疾病成功治疗后LM消失。